Transcriptome analysis reveals what is actually happening in tissues and cells, enabling us to identify biomarkers for new drug development expand markets for existing drugs detect presence of disease assess response to treatment measure expression levels of transcripts identify biomarkers detect new isoforms Identify splicing errors stratify patients identify immune signatures identify new drug targets match patients for clinical trials reassess and revitalize trials ...